ArticleFrontiers in artificial intelligence2025
Early diagnosis of autism across developmental stages through scalable and interpretable ensemble model.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition that challenges early diagnosis due to its diverse manifestations across different developmental stages. Timely and accurate detection is essential to enable interventions that significantly enhance developmental outcomes. This study introduces a robust and interpretable machine learning framework to diagnose ASD using questionnaire data. The proposed framework leverages a stacked ensemble model, combining Random Forest (RF), Extra Tree (ET), and CatBoost (CB) as base classifiers, with an Artificial Neural Network (ANN) serving as the meta-classifier. The methodology addresses class imbalance using Safe-Level SMOTE, dimensionality reduction via Principal Component Analysis (PCA), and feature selection using Mutual Information and Pearson correlation. Evaluation on publicly available datasets representing toddlers, children, adolescents, adults, and a merged dataset (Combining children, adolescents, and adults dataset) demonstrates high diagnostic accuracy, achieving 99.86%, 99.68%, 98.17%, 99.89%, and 96.96%, respectively. Comparative analysis with standard machine learning models underscores the superior performance of the proposed framework. SHapley Additive exPlanations (SHAP) were used to interpret feature importance, while Monte Carlo Dropout (MCD) quantified uncertainty in predictions. This framework provides a scalable, interpretable, and reliable solution for ASD screening across diverse populations and developmental stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.